Not Nvidia. Not Broadcom. Intel Is Going to Be the Biggest Winner of the Artificial Intelligence (AI) Inference Era.

The article argues Intel is well positioned for AI inference demand, citing Deloitte's estimate that inference will consume two-thirds of AI computing power in 2026, up from 50% last year. Intel's server CPU share of just over 71% and its custom ASIC revenue run rate of more than $1 billion are highlighted as evidence that growth is accelerating, aided by contracts with Google and Nvidia. The stock is described as trading at 8.7x sales, with a hypothetical 48% upside if revenue reaches $71 billion by 2028 and the multiple expands to 10x.

Analysis

The market is likely underappreciating how inference changes the value stack: it shifts spend away from a single-chip GPU bottleneck toward a broader architecture where CPUs, networking, memory, and custom silicon all capture share. That is a relative positive for Intel because it monetizes the control plane of the data center, not just the accelerator layer, and that position becomes more valuable as workloads fragment across cloud, edge, and on-device inference. The second-order effect is that buyers will optimize for watts per query and cost per inference, which should favor vendors with integration, supply stability, and existing socket penetration over pure-play speed leaders.

The key near-term catalyst is not a dramatic jump in enterprise AI demand, but a budget reallocation inside hyperscaler capex over the next 2-6 quarters. If inference continues to take a larger share of AI spend, the marginal dollar increasingly goes to deployment density and fleet refresh rather than frontier-training arms races, which is a better setup for Intel’s mix than for the “best accelerator wins everything” narrative. That said, the bull case depends on execution in yields and custom silicon delivery; any slip would quickly push customers back toward incumbent alternatives because inference buyers are far less tolerant of supply uncertainty than training buyers.

The contrarian issue is valuation asymmetry: the stock is being treated like a cyclical recovery story while the narrative is moving toward a structural AI beneficiary. The risk is that investors extrapolate a multi-year earnings inflection too early; if revenue acceleration is linear rather than step-function, multiple expansion will stall and the shares could trade on disappointment despite good fundamentals. For competitors, the hidden loser is anyone dependent on premium accelerator pricing, because inference economics compress pricing power even if unit volumes rise.

Net: this is a better relative-value long than an outright momentum chase. The cleaner expression is to own Intel against a basket of AI winners whose upside is more exposed to training capex intensity, while keeping duration limited until the market sees two more quarters of proof that inference mix is translating into operating leverage.

Key Decisions for Investors

• Long INTC / short a basket of AI hardware beta (NVDA, AVGO) over the next 3-6 months: favor Intel’s relative multiple re-rating if inference-driven CPU and custom-chip demand keeps improving, but cap size because the trade is about mix shift, not absolute industry growth.
• Buy INTC on pullbacks rather than breakouts; use a 2-4 week entry window around post-earnings digestion. Risk/reward improves if the market gives back 5-8% on profit-taking, since the catalyst is multi-quarter adoption, not a one-day event.
• Sell cash-secured puts on INTC 1-2 expiries out at strikes 5-10% below spot to get paid for waiting while limiting downside in a story where supply tightness and customer wins are supporting the floor.
• Pair GOOGL long with INTC only if you want a lower-beta inference exposure through an end-user hyperscaler: Google benefits from lower inference cost and diversified silicon sourcing, but the trade has less torque than outright INTC.
• Avoid chasing NVDA/AVGO here unless there is evidence that inference is accelerating accelerator spend faster than CPU attachment rates; otherwise the risk/reward skews toward the names that gain from architecture diversification rather than peak-GPU pricing.